rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Benjamin Lane

Officer

Company insider

Files Form 4 as: Officer, Nuvalent.

Every Form 4 they filed

In numbers

Trades disclosed
26
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
1 Apr 2026
Last trade
15 Jul 2026
Last filed
15 Jul 2026

Companies traded

Where they are an officer
NuvalentOfficer · Biotechnology · last 15 Jul 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code U$2.6M21,092 at $124.00filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—8,000filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—19,000filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code D—29,433filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code A—7,120 at $0.00filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—731filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—8,333filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—17,848filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—15,052filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—12,025filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—8,000filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivativeSEC FORM 4 Code D—19,000filing
15 Jul 2026filed 15 Jul 2026NuvalentBiotechnologySEC FORM 4 Code D—7,120filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—731filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—8,333filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—17,848filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—15,052filing
15 Jul 2026filed 15 Jul 2026Nuvalentoption or derivative · BiotechnologySEC FORM 4 Code D—12,025filing
15 Jul 2026filed 15 Jul 2026NuvalentSEC FORM 4 Code U$2.6M21,092 at $124.00filing
15 Jul 2026filed 15 Jul 2026NuvalentSEC FORM 4 Code D—29,433filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

James E. FlynnDirector and 10% owner and Other role · Director and 10% owner and Other at Nuvalent, filing Form 4 there in the last year
Ron SquarerDirector · Director at Nuvalent, filing Form 4 there in the last year
Sapna SrivastavaDirector · Director at Nuvalent, filing Form 4 there in the last year
Grant C. BogleDirector · Director at Nuvalent, filing Form 4 there in the last year
Michael L. MeyersDirector · Director at Nuvalent, filing Form 4 there in the last year